Leucemia mielomonocítica juvenil: Relato de caso

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Juvenile myelomonocytic leukemia (JMML) is a rare hematopoietic malignancy, which accounts for 2 to 3% of all pediatric leukemia. JMML is a myeloproliferative disorder characterized by monoclonal overproduction of myeloid cells. The signs and symptoms are a result of the infiltration of monocytic cells into non-hematopoietic organs; the most common symptoms are fever, cough, infection, weakness, pallor, lymphadenopathy, hepatosplenomegaly, skin lesions and bleeding. JMML runs an aggressive clinical course and responds poorly to chemotherapy. Hematopoietic stem cell transplantation is the only curative treatment. We describe the case of a 22-month-old male child, who appeared in the emergency room of Hospital de Clinicas de Porto Alegre because of fever and with a previous diagnosis of mononucleosis made at another Institution. The clinical presentation together with laboratory findings allowed the correct diagnosis. The patient was treated with chemotherapy and underwent hematopoietic stem cell transplantation.

Cite

CITATION STYLE

APA

Farias, M. G., Lucena, N. P., Bó, S. D., Bittar, C. M., Castro, C. G., Gregianin, L. J., & Brunetto, A. L. (2010). Leucemia mielomonocítica juvenil: Relato de caso. Revista Brasileira de Hematologia e Hemoterapia, 32(2), 173–176. https://doi.org/10.1590/S1516-84842010005000041

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free